Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Sanjay Agarwal"'
Autor:
Amit Gupta, Banshi Saboo, Vijay Viswanathan, Arutselvi Devarajan, Satyavani Kumpatla, Sharvari Shukla, Sanjay Agarwal, Brij Mohan Makkar, Vasanth Kumar, Rakesh Kumar Sahay
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 4 (2024)
Introduction Evidence on the prevalence of foot problems among people with diabetes in India at a national level is lacking. Hence, this study was aimed to assess the burden of high-risk (HR) feet in people with diabetes across India.Research design
Externí odkaz:
https://doaj.org/article/088191fb96284f2f82d7f1f26bfe36a6
Publikováno v:
Asian Journal of Medical Sciences, Vol 14, Iss 10, Pp 103-108 (2023)
Background: There is a pressing need for systematic approaches for monitoring how much tuberculosis (TB) treatment is ongoing in the public and private sectors in India, Both to shed light on the true scale of the problem and to help monitor the prog
Externí odkaz:
https://doaj.org/article/54581079286a41dbbf7d0a2cd099f69a
Autor:
Antonio Da Silva, Sanjay Agarwal
Publikováno v:
EJVES Vascular Forum, Vol 61, Iss , Pp S25-S26 (2024)
Externí odkaz:
https://doaj.org/article/fec276b8458e4dc784e194a8768dfa0c
Autor:
Neeta Deshpande, A.H. Mamata, Reshma Parmaj, Sanjay Agarwal, Archana Sarda, Anjali Bhatt, Shilpa Joshi, Nitin Kapoor
Publikováno v:
Clinical Epidemiology and Global Health, Vol 24, Iss , Pp 101397- (2023)
Problems considered: Global challenges posed by obesity, type 2 diabetes mellitus (T2DM), hypertension, and related metabolic diseases necessitate effective interventions. Pharmacotherapy often falls short, leading to a demand for innovative approach
Externí odkaz:
https://doaj.org/article/a98a9aec3adc4181b5c681bbfcbee332
Autor:
Amit Gupta, Banshi Saboo, Jothydev Kesavadev, Manoj Chawla, Rakesh Parikh, Mithun Bhartia, Shashank Joshi, Sanjay Kalra, A G Unnikrishnan, Anuj Maheshwari, Sanjay Agarwal, Brij Makkar, Purvi Chawla, Jayant Panda, Tanvir Kaur, Ashok Kumar Das, Viswanthan Mohan
Publikováno v:
Journal of Diabetology, Vol 14, Iss 4, Pp 183-185 (2023)
Externí odkaz:
https://doaj.org/article/12603450868e4f0ea874a90382e46af1
Publikováno v:
Pharmaceutical and Biomedical Research, Vol 7, Iss 3, Pp 141-160 (2021)
Background: Medicinal herbs remain a vital source of new chemical entities, instead of the attempt of pharmaceutical companies using combinatorial and synthetic chemistry techniques for developing new drugs. Objectives: The primary aim of review is
Externí odkaz:
https://doaj.org/article/2dbefc1fea944574b5fab6c8cf7638f1
Autor:
Banshi Saboo, Sanjay Agarwal, Sunil Gupta, Brij Makkar, A Panneerselvam, Abhay Kumar Sahoo, G D Ramchandani, Sambit Das, Suhas Erande, Yogesh Kadam, Mahesh V Abhyankar, Santosh Revankar
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 10, Iss 9, Pp 3444-3452 (2021)
Objective: To assess the clinical characteristics, risk factors, and comorbidities associated with type 2 diabetes mellitus (T2DM) in young adult patients. Methods: This is a retrospective, multicentric real-world study that included young adults (18
Externí odkaz:
https://doaj.org/article/9b7c4696a2f042e8bbd398b5681bb222
Publikováno v:
Toxicology Reports, Vol 8, Iss , Pp 223-229 (2021)
The study was aimed at assessing isoprenaline (ISO) induced oxidative damage in brain of Wistar rats and its protection by hydroethanolic hull extract of Juglans regia. Administration of ISO significantly increases catalase (CAT), superoxide dismutas
Externí odkaz:
https://doaj.org/article/d7936b8c730244b6b0c2eaaa9ec058ca
Publikováno v:
Pharmaceutical and Biomedical Research, Vol 4, Iss 2, Pp 1-17 (2018)
Calendula officinalis Linn. commonly known as marigold has long history of usage by the folklore system. It has a high economic value as herbal medicine and is widely used in cosmetics, perfumes, dyes, pharmaceutical preparations and food products fo
Externí odkaz:
https://doaj.org/article/763c7bdd1ae6441a8df22f1ff9dc3f79
Publikováno v:
CVIR Endovascular, Vol 1, Iss 1, Pp 1-4 (2018)
Abstract Background Coil embolisation of the internal iliac arteries prior to EVAR is considered standard treatment to prevent a type 2 endoleak when extending an iliac limb into the EIA. Type 2 endoleaks that arise from a non-coil-embolised internal
Externí odkaz:
https://doaj.org/article/9862a21739db4fcb8e11325c13f62f79